Literature DB >> 20198326

Neoplastic progression of the human breast cancer cell line G3S1 is associated with elevation of cytoskeletal dynamics and upregulation of MT1-MMP.

Ondrej Tolde1, Daniel Rösel, Claudia T Mierke, Daniela Panková, Petr Folk, Pavel Vesely, Jan Brábek.   

Abstract

The newly established breast cancer cell line G3S1, derived from EM-G3 breast cancer progenitors, was analyzed for functional changes related to neoplastic progression manifested by elevated invasiveness and enhanced capability to degrade gelatin. Degradation of gelatin and invasiveness of G3S1 cells was found to be dependent on the activity of matrix proteinases and actin cytoskeletal dynamics. Therefore, the expression and activity of these proteases was compared in G3S1 and EM-G3 cells. Despite enhanced capability of G3S1 cells to degrade gelatin, these cells exhibited lower levels of secreted extracellular matrix degrading proteases than parental EM-G3 cells. However, the expression of membrane-bound MT1-MMP was strongly elevated in G3S1 cells. While the degradation of gelatin was associated with invadopodia-like structures in both EM-G3 and G3S1 cells, the cytoskeletal remodeling dynamics was greatly elevated in G3S1 cells, suggesting that upregulation of MT1-MMP, together with elevation of cytoskeletal remodeling dynamics can effectively cause elevated invasiveness and enhanced matrix degrading capability in G3S1 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198326     DOI: 10.3892/ijo_00000560

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer.

Authors:  Yu-Zhou Wang; Kun-Peng Wu; Ai-Bing Wu; Zhi-Cheng Yang; Jin-Mei Li; Yan-Li Mo; Meng Xu; Bin Wu; Zhi-Xiong Yang
Journal:  Tumour Biol       Date:  2014-07-02

Review 2.  Targeting the cytoskeleton against metastatic dissemination.

Authors:  Carmen Ruggiero; Enzo Lalli
Journal:  Cancer Metastasis Rev       Date:  2021-01-20       Impact factor: 9.264

3.  Tyrosine phosphorylation within the SH3 domain regulates CAS subcellular localization, cell migration, and invasiveness.

Authors:  Radoslav Janoštiak; Ondřej Tolde; Zuzana Brůhová; Marian Novotný; Steven K Hanks; Daniel Rösel; Jan Brábek
Journal:  Mol Biol Cell       Date:  2011-09-21       Impact factor: 4.138

4.  Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.

Authors:  Ilya Ulasov; Bart Thaci; Purvaba Sarvaiya; Ruiyang Yi; Donna Guo; Brenda Auffinger; Peter Pytel; Lingjiao Zhang; Chung Kwon Kim; Anton Borovjagin; Mahua Dey; Yu Han; Anatoly Y Baryshnikov; Maciej S Lesniak
Journal:  Cancer Med       Date:  2013-06-30       Impact factor: 4.452

5.  Role of c-Src activity in the regulation of gastric cancer cell migration.

Authors:  Yun Yang; Zhi-Gang Bai; Jie Yin; Guo-Cong Wu; Zhong-Tao Zhang
Journal:  Oncol Rep       Date:  2014-05-15       Impact factor: 3.906

6.  [MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells].

Authors:  Aibing Wu; Jinmei Li; Kunpeng Wu; Yanli Mo; Yiping Luo; Haiyin Ye; Xiang Shen; Shujun Li; Yahai Liang; Meilian Liu; Zhixiong Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-07

Review 7.  Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.

Authors:  Aneta Gandalovičová; Daniel Rosel; Michael Fernandes; Pavel Veselý; Petr Heneberg; Vladimír Čermák; Luboš Petruželka; Sunil Kumar; Victoria Sanz-Moreno; Jan Brábek
Journal:  Trends Cancer       Date:  2017-06

8.  PROX1 is a transcriptional regulator of MMP14.

Authors:  Silvia Gramolelli; Jianpin Cheng; Ines Martinez-Corral; Markus Vähä-Koskela; Endrit Elbasani; Elisa Kaivanto; Ville Rantanen; Krista Tuohinto; Sampsa Hautaniemi; Mark Bower; Caj Haglund; Kari Alitalo; Taija Mäkinen; Tatiana V Petrova; Kaisa Lehti; Päivi M Ojala
Journal:  Sci Rep       Date:  2018-06-22       Impact factor: 4.379

9.  MT1-MMP is not a good prognosticator of cancer survival: evidence from 11 studies.

Authors:  Kun-Peng Wu; Qiang Li; Fu-Xiang Lin; Jun Li; Lu-Min Wu; Wei Li; Qiao-Zhu Yang
Journal:  Tumour Biol       Date:  2014-09-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.